/Companies

Kadence Bio

1 known investors

Find your way into Kadence Bio

Kadence Bio is a clinical-stage life sciences company developing therapeutics for conditions in sexual and mental health. Its lead asset, KH-001, is being developed as an FDA-approved treatment for premature ejaculation, alongside a pipeline of compounds targeting mood disorders.

Investors · 1

Frequently asked questions

What does Kadence Bio do?
Kadence Bio is a clinical-stage life sciences company developing therapeutics for conditions in sexual and mental health. Its lead asset, KH-001, is being developed as an FDA-approved treatment for premature ejaculation, alongside a pipeline of compounds targeting mood disorders.
Who are Kadence Bio's investors?
Kadence Bio's investors include Palo Santo VC.